Several studies reported that systemic IgA anti-SARS-CoV-2 is often detectable earlier than either IgM or IgG and that higher systemic levels of SARS-CoV-2-specific IgA detectable early in the course of infection are associated with severe illness [28,29,30]. Here, CD79A is linked to infection.